|
|
|
| Chocamine Description |
| By David Tolson |
|
|
| Product |
Price |
Type |
| Chocamine Powder |
$14.99 |
100 grams |
 |
| Displaying 1 to 1 (of 1 products) |
Result Pages: 1 |
|
| Introduction
Chocamine is a proprietary cocoa extract meant to provide the stimulation
and health benefits of chocolate without any of the unnecessary, potentially
unhealthy ingredients (such as sugar and fat). It contains numerous constituents,
including methylxanthines (theobromine, caffeine, and theophylline), biogenic
amines (phenylethylamine, tyramine, and according to one source, synephrine),
amino acids (phenylalanine, tryptophan, tyrosine, others), minerals (with
a high content of magnesium), numerous beneficial antioxidants, and possibly
some non-psychoactive cannabanoid-related compounds. The combination of these
multiple ingredients produces a unique effect. Promotional literature makes
many positive claims about Chocamine, including increased energy, appetite
suppression, increased lipolysis (fat burning), improved mood, improved concentration,
increased alertness, improved physical performance, aphrodisiac properties,
and health benefits. This article will examine the properties of some of
the known constituents of Chocamine.
Methylxanthines
The methylxanthines are a group of compounds that include caffeine and some
related stimulants. Chocamine contains methylxanthines such as theobromine,
caffeine, and theophylline. Each gram of Chocamine contains 120 mg theobromine
and 80 mg caffeine.
Caffeine is one of the most well-known stimulants, and functions primarily
via antagonism of adenosine receptors. The properties of acute caffeine administration
to humans include increased exercise performance, appetite suppression, increased
rate of lipolysis, increased alertness, and reduced fatigue. Preliminary
evidence suggests that regular consumption of small amounts of caffeine may
also have neuroprotective properties. On the other hand,
caffeine is best avoided in those with high blood pressure and those prone
to anxiety.
Theobromine is similar in both structure and function to caffeine, but it
has a longer half-life, which may be one of the reasons chocamine has the
reputation of being a "long-lasting stimulant." Theobromine also has a relative
potency a few orders of magnitude lower than caffeine, but the amount in
Chocamine (assuming a gram or more is taken) is still enough to have a psychoactive
effect.
Theophylline is one of the most commonly used asthma medications due to its
bronchodilating properties, and phosphodiesterase inhibition seems to play
a relatively larger role in its pharmacologic activity compared to caffeine.
Theophylline is also quite lipolytic, and in vitro studies indicate that
it is more lipolytic than caffeine in equivalent concentrations, but it is
unknown whether or not the amount in Chocamine is enough to have a significant
effect.
Biogenic amines
Biogenic amines are neurotransmitter-related compounds such as synephrine,
tyramine, octopamine, and phenylethylamine; these compounds are also commonly
referred to as "false neurotransmitters," but the recent discovery of a specific
receptor for these compounds in humans may have made this term obsolete.
Nevertheless, they have many known actions in humans related to their effects
on conventional receptors. Chocamine contains both phenylethylamine (PEA)
and tyramine. One website indicates that it also contains synephrine, but
I have been unable to confirm this as of yet.
PEA is a naturally occurring compound that behaves as a stimulant in the brain,
with effects similar to those of amphetamine. However, oral bioavailability
of PEA is very low, and there is not strong support for the contention that
oral administration could yield a psychoactive effect, as many studies have
come out negative. Some individuals may be particularly sensitive to the
effects of oral PEA. Also, administration with an inhibitor of MAO-B renders
PEA orally bioavailable.
Tyramine is another biogenic amine found in Chocamine. Tyramine is also found
in relatively high concentrations in some foods such as aged cheese and wine.
In insects, tyramine plays a similar role as a neurotransmitter to the role
that epinephrine plays in mammals. In humans, tyramine can cause a release
of norepinephrine. Tyramine is orally bioavailable, but unless an MAO inhibitor
is being taken, large doses are required to exert an effect. It is unlikely
that Chocamine contains a high enough amount of tyramine to have a significant
effect, but it is possible that the tyramine content offers a mild contribution
in terms of appetite suppression and lipolysis.
Synephrine is another related compound (a metabolite of tyramine), and it
is an alpha(1) agonist. Synephrine has a higher oral bioavailability than
most of the other trace amines. Because of its alpha(1) agonist properties,
synephrine may be effective at decreasing appetite and promoting lipolysis.
Amino acids
Chocamine contains amino acids such as phenylalanine, tyrosine, and tryptophan.oth
phenylalanine and tyrosine have stimulant effects.
Tryptophan is the amino acid precursor to serotonin (5-HT), with 5-HTP as
the intermediary. Many clinical studies suggest that tryptophan is an effective
antidepressant, although it is not as reliably effective as 5-HTP. This is
possibly due to the fact that there are more mechanisms that inhibit tryptophan
transport across the blood brain barrier and conversion to serotonin. On
top of this, it is unlikely that the amounts present in Chocamine are large
enough to cause a significant change in brain serotonin status. Either way, the
presence of this amino acid can be considered a possible benefit. Tryptophan
is yet another compound in chocamine that may contribute to appetite suppression.
Tyrosine is the precursor to the neurotransmitter dopamine (DA). In humans,
tyrosine supplementation leads to increased dopamine and norepinephrine levels
in the brain without competitive inhibition of other amino acids.
Minerals
Chocamine is reported to be rich in both magnesium and copper. There is generally
no need for extra copper, although zinc, chromium, and vitamin C can all
inhibit copper absorption to an extent. However, extra magnesium is generally
beneficial. Other minerals
found in chocolate, and presumably also present in Chocamine, are calcium
and potassium.
Phytonutrients
Cocoa contains both plant sterols and fiber, both of which support cardiovascular health, but the sterol content is low (and probably even
lower when the fat is removed), and the fiber is lost with processing. However,
cocoa contains high quantities of flavanoids (a class of polyphenols), including
proanthocyanidins and the flavan-3-ols catechen and epicatechin, and according
to the promotional literature, Chocamine is high in these compounds (and
this is undoubtedly the case, since they are quite easy to extract). The
content and makeup of these phytonutrients in chocolate is similar to that
in apples (it is higher on a per weight basis, but less on a per calorie
basis). Chocolate has been found to increase the content of these flavan-3-ols
and proanthocyanidins in the bloodstream in humans. Other studies indicate that
the antioxidant capacity of chocolate is comparable with that of garlic,
blueberries, and strawberries.
Conclusions
Chocamine contains many beneficial ingredients, especially if one is looking
for CNS stimulation and appetite suppression. The effects could be compared
to those of amphetamine, but not as potent or euphoric. Although it is likely
that only 5 or 6 of the compounds in Chocamine are found in sufficient quantity
to exert an effect, the combination of the many ingredients together will
offer many subtleties and make for a rather unique supplement. This is a
supplement that should be definitely avoided by those prone to anxiety attacks
or with cardiovascular conditions because of the stimulating effects. Like
other stimulants, it shouldn't be used before bed, and caution is strongly
advised when combining with other stimulants. Recommended dosage is 1 gram
1-3 times daily (if in doubt, start low and move up). Although Chocamine
undoubtedly is quite effective on its own, the following supplements may
have additive benefits when used at the same time.
- 5-HTP Chocamine
may also help counteract the drowsiness/fatigue that some report from 5-HTP.
- Green tea extract can be used to
increase the flavanoid content, provide further health benefits, and increase
fat burning. Green tea extract is one of the least expensive and most potent
sources of phytonutrients.
- D,L-phenylalanine and/or L-tyrosine can both be used to increase the
content of these amino acids. The D form of phenylalanine, not found in Chocamine, will also have some unique benefits (see the DL-phenylalanine
article).
- Yohimbine is lipolytic, and an appetite
suppressant, and will add on to the reputed sexual support effects of Chocamine.
It is also synergistic with methylxanthines for fat loss. However, a high
degree of caution is advised when stacking these (start low to monitor your
reaction), and it is also likely to cause significant anxiety in those who
are prone to it.
If you have any questions or comments regarding this article, please email
dvdtlsn@bulknutrition.com. No part of this article may be reproduced in any form without the permission of David Tolson or Mike McCandless. |
|
References |
Acta Pharmacol Toxicol (Copenh). 1984 Jan;54(1):64-71. The effect of alkylxanthines
and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease
in lipolysis and cyclic AMP accumulation in rat fat cells. Fredholm BB, Lindgren
E.
Altern Med Rev. 2000 Feb;5(1):64-71. Use of neurotransmitter precursors for
treatment of depression. Meyers S.
Am J Clin Nutr. 2003 Jun;77(6):1442-7. Effect of chewing gum containing nicotine
and caffeine on energy expenditure and substrate utilization in men. Jessen
AB, Toubro S, Astrup A.
Am J Physiol Regul Integr Comp Physiol. 2003 Feb;284(2):R399-404. Epub 2002
Oct 24. Central nervous system effects of caffeine and adenosine on fatigue.
Davis JM, Zhao Z, Stock HS, Mehl KA, Buggy J, Hand GA.
Ann Neurol. 2001 Jul;50(1):56-63. Prospective study of caffeine consumption
and risk of Parkinson's disease in men and women. Ascherio A, Zhang SM, Hernan
MA, Kawachi I, Colditz GA, Speizer FE, Willett WC.
Arch Insect Biochem Physiol. 2003 Sep;54(1):1-13. Tyramine and octopamine:
antagonistic modulators of behavior and metabolism. Roeder T, Seifert M,
Kahler C, Gewecke M.
Brain Res. 1976 Sep 10;114(1):105-15. Pathways linking L-phenylalanine and
2-phenylethylamine with p-tyramine in rabbit brain. Silkaitis RP, Mosnaim
AD.
Br J Clin Pharmacol. 1986 Aug;22(2):177-82. Comparative pharmacokinetics
of caffeine and its primary demethylated metabolites paraxanthine, theobromine
and theophylline in man. Lelo A, Birkett DJ, Robson RA, Miners JO.
Br J Nutr. 2001 Feb;85(2):203-11. Combined effects of red pepper and caffeine
consumption on 24 h energy balance in subjects given free access to foods.
Yoshioka M, Doucet E, Drapeau V, Dionne I, Tremblay A.
Br J Pharmacol. 1988 Feb;93(2):417-29. Activities of octopamine and synephrine
stereoisomers on alpha-adrenoceptors. Brown CM, McGrath JC, Midgley JM, Muir
AG, O'Brien JW, Thonoor CM, Williams CM, Wilson VG.
Cancer Lett. 2003 May 8;194(1):25-35. Mechanistic approach of contrasting
modifying effects of caffeine on carcinogenesis in the rat colon and mammary
gland induced with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Takeshita
F, Ogawa K, Asamoto M, Shirai T.
Clin Chim Acta. 2000 Apr;294(1-2):1-26. Magnesium. An update on physiological,
clinical and analytical aspects. Saris NE, Mervaala E, Karppanen H, Khawaja
JA, Lewenstam A.
Clin Exp Pharmacol Physiol. 2002 May-Jun;29(5-6):391-4. Effects of caffeine
on the uncoupling protein family in obese yellow KK mice. Kogure A, Sakane
N, Takakura Y, Umekawa T, Yoshioka K, Nishino H, Yamamoto T, Kawada T, Yoshikawa
T, Yoshida T.
Eur J Neurol. 2002 Jul;9(4):377-82. Does caffeine intake protect from Alzheimer's
disease? Maia L, de Mendonca A.
Exp Biol Med (Maywood). 2001 Nov;226(10):891-7. Chemopreventive effects of
cocoa polyphenols on chronic diseases. Weisburger JH.
J Am Diet Assoc. 2003 Feb;103(2):215-23. Cocoa and chocolate flavonoids:
implications for cardiovascular health. Steinberg FM, Bearden MM, Keen CL.
J Appl Physiol. 2002 Oct;93(4):1227-34. Exercise endurance 1, 3, and 6 h
after caffeine ingestion in caffeine users and nonusers. Bell DG, McLellan
TM.
J Clin Endocrinol Metab 1983 Oct;57(4):760-3. Effects of tyrosine and tryptophan
ingestion on plasma catecholamine and 3,4-dihydroxyphenylacetic acid concentrations.
Rasmussen DD, Ishizuka B, Quigley ME, Yen SS.
J Clin Pharmacol. 2003 Jun;43(6):604-9. Tyramine pharmacokinetics and reduced
bioavailability with food. VanDenBerg CM, Blob LF, Kemper EM, Azzaro AJ.
J Exp Clin Cancer Res. 2001 Jun;20(2):287-92. Effect of Caffeine, a xanthine
derivative, in the inhibition of experimental lung metastasis induced by
B16F10 melanoma cells. Gude RP, Menon LG, Rao SG.
J Lipid Res. 1993 Oct;34(10):1737-43. Effect of phosphodiesterase inhibition
with amrinone or theophylline on lipolysis and blood flow in human adipose
tissue in vivo as measured with microdialysis. Arner P, Hellmer J, Hagstrom-Toft
E, Bolinder J.
J Neural Transm 1980;47(4):299-306. Plasma tyrosine in normal humans: effects
of oral tyrosine and protein-containing meals. Melamed E, Glaeser B, Growdon
JH, Wurtman RJ.
J Neural Transm. 1984;59(1):81-7. L-deprenyl plus L-phenylalanine in the
treatment of depression. Birkmayer W, Riederer P, Linauer W, Knoll J.
J Neurol Neurosurg Psychiatry. 1977 Feb;40(2):179-85. Effects of oral amines
on the EEG. Scott DF, Moffett AM, Swash M.
J Neuropsychiatry Clin Neurosci. 1996 Spring;8(2):168-71. Sustained antidepressant
effect of PEA replacement. Sabelli H, Fink P, Fawcett J, Tom C.
J Pharmacol Exp Ther 1990 Nov;255(2):403-9. L-tyrosine potentiates the anorexia
induced by mixed-acting sympathomimetic drugs in hyperphagic rats. Hull KM,
Maher TJ.
Neurosci Lett. 1996 Aug 23;214(2-3):107-10. Antidepressant-like effects of
p-synephrine in mouse models of immobility tests. Song DK, Suh HW, Jung JS,
Wie MB, Son KH, Kim YH.
Psychopharmacology (Berl). 1994 Jun;115(1-2):1-8. Discriminative stimulus
and subjective effects of theobromine and caffeine in humans. Mumford GK,
Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR.
Nutr Neurosci. 2003 Aug;6(4):237-46. Effects of tyrosine, phentermine, caffeine
D-amphetamine, and placebo on cognitive and motor performance deficits during
sleep deprivation. Magill RA, Waters WF, Bray GA, Volaufova J, Smith SR,
Lieberman HR, McNevin N, Ryan DH.
Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(5):611-23. Effect of dietary
phenylalanine on the plasma concentrations of phenylalanine, phenylethylamine
and phenylacetic acid in healthy volunteers. Davis BA, O'Reilly RL, Placatka
CL, Paterson IA, Yu PH, Durden DA. |
|
|
|
|
|
|